Session 1: Learning from recorded TAVR case step by step
| Main Arena | 13:30-14:50
Chairpersons:Yan WANG Ben HE Jun JIANG
Time
Speaker
Title
13:30-13:40
Xianbao LIU
Clinical evaluation
13:40-13:50
Lei YU
Echo Evaluation
13:50-14:00
Yuxin HE
CT analysis
14:00-14:10
Jian’an WANG Aiqiang DONG Xianbao LIU Wei HE Zhaoxia PU Yuxin HE Jifang CHENG
Heart valve team discussion (cardiologist, surgeon, anesthesiologist, radiologist, nurse)
14:10-14:30
Jian’an WANG
Recorded TAVR case step by step
14:30-14:50
Discussion
14:50-15:00
Coffee and Tea Break
Session 2: Optimising TAVR outcomes
| Main Arena | 15:00-16:20
Chairpersons:Horst SIEVERT Jian’an Wang Yongjian WU Qiang WU Sung-Han YOON Paul CHIAM
Time
Speaker
Title
15:00-15:10
Eberhard GRUBE
Optimiaing TAVR Outcomes:Where are the Limits
15:10-15:20
Mao CHEN
TF-TAVR: How to evaluate and get vascular access safe
15:20-15:30
Yingqiang GUO
TA-TAVR: Access evaluation and procedural consideration
15:30-15:40
Jian’an WANG
Super Stiff wire and pre-dilation balloon selection and manipulation
15:40-15:50
Wei-Hsian YIN
How to choose correct THV and valve size
15:50-16:00
Thomas MODINE
Double S curve guided deployment
16:00-16:20
Discussion
16:20-16:40
Coffee and Tea Break
Session 3: Making TAVR simple
| Main Arena | 16:40-18:00
Chairpersons:Yong HUO Mao CHEN Wei-Hsian YIN Atiq REHMAN Norio TADA Guangyuan SONG
Time
Speaker
Title
16:40-16:50
Yung-Tsai LEE
TTE or TEE guidance?
16:50-17:00
Duk-Woo PARK
Local or general anesthesia?
17:00-17:10
Michael Kang-Yin LEE
Shall we skip balloon pre-dilation?
17:10-17:20
Yat-Yin LAM
Hybrid or ordinary catheter room?
17:20-17:30
Yongjian WU
Will TAVR be performed as PCI in the future?
17:30-17:40
Horst SIEVERT
Will heart valve team be changed in the future?
17:40-18:00
Discussion
Hands on simulator training with self-expanding VENUS A valve
| No. 6 Meeting Room | 15:00-18:00
Hands on simulator training with Lotus valve
| No. 5 Meeting Room | 15:00-18:00
4月15日
Session 4: Moving forward to lower risk patients
| Main Arena | 08:00-09:00
Chairpersons:Jian’an WANG Bo XU Khalil FATTOUCH Anthony WALTON Meixiang XIANG Wenzhi PAN
Time
Speaker
Title
08:00-08:10
Ulrich GERCKENS
What’s the real difference between high risk and lower risk patients
08:10-08:20
Eberhard GRUBE
The limitations of surgery in lower risk patients-perspectives from interventionalist
08:20-08:30
Jeng WEI
The limitations of TAVR in lower risk patients-perspectives from surgeon
08:30-08:40
Junbo GE
Latest evidence and limitations
08:40-09:00
Discussion
09:00-09:20
Opening ceremony
Session 5: Dialogues of TAVR between China and the world
| Main Arena | 09:30-10:30
Chairpersons: Junbo GE Horst SIEVERT
Panelists: Eberhard GRUBE Shah Hinan AHMED Jeng WEI Mao CHEN Thomas MODINE Sung-Han YOON
Time
Speaker
Title
09:30-10:20
Topics including: 1. Current status of TAVR in China and in the world 2. Bicuspid aortic valve 3. Home-made devices4.Perspectives from cardiologists and surgeons
10:20-10:30
Junbo GE
Summary
Session 6: Live cases
| Main Arena | 10:30-12:00
Chairpersons:Junbo GE Eberhard GRUBE Bo XU Khalil FATTOUCH Michael Kang-Yin LEE Dongming HOU Daxin ZHOU
Time
Speaker
Title
10:30-11:30
Jian’an WANG Xianbao LIU
TAVR live case
11:30-12:00
Robert GOOLEY
Recorded TAVR case
12:00-13:30
Lunch Break (in the meeting room)
Session 7: TAVR in Asia
| Main Arena | 12:15-13:20
